These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10565819)

  • 1. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier.
    Fenart L; Casanova A; Dehouck B; Duhem C; Slupek S; Cecchelli R; Betbeder D
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1017-22. PubMed ID: 10565819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro.
    Jallouli Y; Paillard A; Chang J; Sevin E; Betbeder D
    Int J Pharm; 2007 Nov; 344(1-2):103-9. PubMed ID: 17651930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
    Lu W; Tan YZ; Hu KL; Jiang XG
    Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.
    Lu W; Tan YZ; Jiang XG
    Yao Xue Xue Bao; 2006 Apr; 41(4):296-304. PubMed ID: 16856472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of cationized anti-tetanus Fab'2 fragments across an in vitro blood-brain barrier model: involvement of the transcytosis pathway.
    Girod J; Fenart L; Régina A; Dehouck MP; Hong G; Scherrmann JM; Cecchelli R; Roux F
    J Neurochem; 1999 Nov; 73(5):2002-8. PubMed ID: 10537059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of glial cells against lipopolysaccharide-mediated blood-brain barrier injury.
    Descamps L; Coisne C; Dehouck B; Cecchelli R; Torpier G
    Glia; 2003 Apr; 42(1):46-58. PubMed ID: 12594736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier.
    Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.
    Lu W; Wan J; She Z; Jiang X
    J Control Release; 2007 Mar; 118(1):38-53. PubMed ID: 17240471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorpyrifos alters functional integrity and structure of an in vitro BBB model: co-cultures of bovine endothelial cells and neonatal rat astrocytes.
    Parran DK; Magnin G; Li W; Jortner BS; Ehrich M
    Neurotoxicology; 2005 Jan; 26(1):77-88. PubMed ID: 15527875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.
    Chen H; Tang L; Qin Y; Yin Y; Tang J; Tang W; Sun X; Zhang Z; Liu J; He Q
    Eur J Pharm Sci; 2010 May; 40(2):94-102. PubMed ID: 20298779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
    Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
    Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection.
    Mukhtar M; Pomerantz RJ
    J Hum Virol; 2000; 3(6):324-34. PubMed ID: 11100913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study.
    Santaguida S; Janigro D; Hossain M; Oby E; Rapp E; Cucullo L
    Brain Res; 2006 Sep; 1109(1):1-13. PubMed ID: 16857178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hypoxia on endothelial/pericytic co-culture model of the blood-brain barrier.
    Hayashi K; Nakao S; Nakaoke R; Nakagawa S; Kitagawa N; Niwa M
    Regul Pept; 2004 Dec; 123(1-3):77-83. PubMed ID: 15518896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.
    Weiss CK; Kohnle MV; Landfester K; Hauk T; Fischer D; Schmitz-Wienke J; Mailänder V
    ChemMedChem; 2008 Sep; 3(9):1395-403. PubMed ID: 18613205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromagnetic fields (1.8 GHz) increase the permeability to sucrose of the blood-brain barrier in vitro.
    Schirmacher A; Winters S; Fischer S; Goeke J; Galla HJ; Kullnick U; Ringelstein EB; Stögbauer F
    Bioelectromagnetics; 2000 Jul; 21(5):338-45. PubMed ID: 10899769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
    Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
    Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier.
    Monnaert V; Betbeder D; Fenart L; Bricout H; Lenfant AM; Landry C; Cecchelli R; Monflier E; Tilloy S
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1115-20. PubMed ID: 15280439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.